The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

A recent article posted to the medRxiv* preprint server assessed the potency of tixagevimab/cilgavimab in averting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vaccinated immunocompromised people. Study: Tixagevimab/Cilgavimab for Prevention of COVID-19 during the Omicron Surge: Retrospective Analysis of…

Read More